About the Program

The Cancer Prevention and Control Program of the Mayo Clinic Cancer Center conducts innovative research on the prevention of cancer and seeks to improve the lives of people with cancer by studying the control of cancer symptoms and cancer treatment side effects.

Research initiatives

The Cancer Prevention and Control Program engages in two main areas of cancer research:

  • Cancer risk reduction, including chemoprevention, tobacco control and early-detection research. Research efforts focus on inhibition of preinvasive neoplasia, reducing tobacco exposure, early detection to identify asymptomatic tumors at the earliest possible stage, and tobacco control to preclude or reduce tobacco exposure.
  • Cancer survivorship and control of cancer symptoms. Research on cancer survivorship and cancer symptoms involves studies that improve cancer care by eliminating or controlling cancer symptoms and cancer treatment side effects to optimize quality of life and longevity after a cancer diagnosis.

The program conducts research at all three Mayo Clinic campuses — in Phoenix/Scottsdale, Arizona; Jacksonville, Florida; and Rochester, Minnesota.

Program leadership

The Cancer Prevention and Control Program at Mayo Clinic is directed by Paul J. Limburg, M.D., M.P.H., and Charles L. Loprinzi, M.D.

  • Dr. Limburg, a gastroenterologist, is a professor of medicine in the Mayo Clinic College of Medicine and Science in Rochester, Minnesota. Dr. Limburg's clinical and research interests are focused on chronic disease prevention, with specific emphases on chemoprevention, molecular epidemiology and early detection.
  • Dr. Loprinzi, a medical oncologist, is a professor of oncology in the Mayo Clinic College of Medicine and Science in Rochester, Minnesota. Dr. Loprinzi has dedicated his research career to developing better treatment approaches for uncontrolled symptoms in patients with cancer and has led a group that has conducted more than 150 symptom-control clinical trials.

Affiliations

The Cancer Prevention and Control Program is affiliated with other Mayo Clinic research areas, including: